Aquestive Therapeutics, Inc. ($AQST)
Davis Matthew W. โ Chief Development Officer
Shares
5,303
Price
$3.52
Total Value
$18,666.56
Nearby Earnings
Nov 4, 2026
EPS:Est: -0.10
Revenue:Est: $11.02M
Transaction Details
| Insider | Davis Matthew W. |
|---|---|
| Title | Chief Development Officer |
| Transaction Date | Nov 10, 2026 |
| Transaction Code | F Tax Withholding |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Nov 12, 2026 |
| Shares Purchased | 5,303 |
| Price per Share | $3.52 |
| Total Value | $18,666.56 |
| Shares Owned After | 94,697 |
| Derivative | No |
| Accession Number | 0001214659-26-014000 |
| Document | View SEC Filing |